/L (1 ).
Neutropenia is frequently observed in neonates. It has been reported to occur in as many as 6% to 17% of all neonates admitted to intensive care units (2 ) . The incidence of neutropenia is highest among preterm infants and rises with decreasing birth weight. In most cases, neutropenia is transient and confers no survival disadvantage. Some hematologic disorders and immunodeficiency diseases leading to neutropenia (e.g., Kostmann syndrome) may become apparent in the neonatal period, but these etiologies are rare. In the neonatal period, neutropenia suggests 4 common etiologies: (a) bacterial infection, (b) neonatal alloimmune neutropenia (NAIN), (c) neutropenia related to maternal hypertension, or (d) congenital viral infections (3 ) .
The diagnostic approach is based on family and maternal history (neonatal neutropenia or unexplained death in siblings, maternal hypertension) and on clinical examination of both the mother and the newborn to identify any sign of infection. Examination of the mouth, rectum, and perineum is particularly important. Initial investigation should include cultures (blood, gastric aspirate, and ear swab), C-reactive protein and procalcitonin concen-tration determinations, and microscopic examination of a blood smear. Additional tests could include viral testing (e.g., cytomegalovirus, Epstein-Barr virus, and parvovirus B19, as clinically indicated) and testing for granulocyte antibodies, which are pathognomonic of NAIN (3 ) .
NAIN is caused by feto-maternal granulocyte incompatibility. It is considered the granulocyte counterpart of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and of hemolytic disease of the newborn (HDN). NAIN results from neutrophilic destruction by transplacentally acquired maternal neutrophilspecific IgG antibodies directed against paternally derived antigens. Although granulocytes express HLA class I at their surface, NAIN is mainly due to alloantibodies directed against neutrophil-specific antigens. Currently, the human neutrophil antigen (HNA) system comprises 7 antigens that are assigned to 5 glycoproteins (antigen systems) ( Table 1 ) (4 ). Anti-HNA-1a and anti-HNA-1b have been the most commonly reported to cause NAIN. Anti-HNA-2a and antiFc␥RIIIb (also known as CD16) in mothers with an GAT Serum from the patient is incubated with a granulocyte suspension. The reaction is graded from negative to 4ϩ on the basis of the percentage of cells that are agglutinated.
Possible false-positive results due to spontaneous agglutination of neutrophils.
Indirect GIFT Serum from the patient is incubated with a granulocyte suspension. After a wash step, bound antibodies to granulocytes are detected using a fluoresceinated human antiimmunoglobulin.
Possible false-positive results due to immune complexes.
MAIGA
Granulocytes are incubated with the serum from the patient. This granulocyte suspension is washed and incubated with a murine monoclonal antibody to a specific neutrophil glycoprotein. After another wash step, the granulocyte membranes are disrupted. The resulting lysate is then transferred to microwells coated with antimouse immunoglobulins. Detection of the trimolecular neutrophil antigen-patient HNA antibody-murine monoclonal antibody complex is detected by the addition of antihuman IgG conjugated to horseradish peroxidase followed by a substrate.
Very complex test requiring highly skilled staff.
a Clay et al. (6 ) .
HNA-null phenotype [i.e., FcR␥IIIb deficiency (Box 1)] are more rarely involved (5 ).
Demonstration of granulocyte antibodies must be performed by using a minimum of 2 methods, the granulocyte agglutination test (GAT), the indirect granulocyte immunofluorescence test (GIFT), or the monoclonal antibody-specific immobilization of granulocyte antigen (MAIGA) assay (Table 2) . Antibody identification is verified by determination of maternal, paternal, and neonatal human neutrophil antigens (HNA). The mother will be antigen negative to the alloantibody present in maternal/neonatal serum. The father and neonate will be antigen positive. PCR with sequence-specific primers (PCR-SSP) is most widely used for HNA genotyping (7 ) .
In this case, IgG antigranulocyte antibodies were detected at a high level in maternal serum using GIFT but were negative with GAT even after serum dilution (from 1:2 to 1:512). A high concentration of anti-CD16 was identified by MAIGA, with maternal neutrophils being typed as CD16 negative. HNA system 1 (HNA-1) genotyping was performed by PCR-SSP. The mother was negative for HNA-1a, -1b, and -1c, consistent with an Fc␥RIIIb deficiency, whereas the newborn and the father were positive for HNA-1a and -1b and negative for -1c. NAIN due to anti-Fc␥RIIIb antibodies was diagnosed.
NAIN is an uncommon disorder, with an estimated incidence 1 in 2000 live births. This is probably an underestimation, however, because NAIN is often clinically silent, as in the current case. A prospective study, performed in an intensive care unit, showed that NAIN causes 2.9% of neonatal neutropenia (2 ) .
The exact mechanism underlying maternal immunization remains unknown. The rate of alloimmunization is variable and depends on the frequency of the antigens in the population and on their immunogenicity. However, as for RHD and FNAIT, NAIN incidence is lower than alloimmunization incidence, which is itself lower than the feto-maternal incompatibility.
Like FNAIT, and contrary to HDN due to Rh (and most other red cell antigens except ABO), NAIN can occur during a first pregnancy. There is no risk to the baby during pregnancy, and the course of pregnancy is uneventful. The neonate is usually asymptomatic, with neutropenia often being found incidentally. Sometimes the neonate may develop a mild infection (e.g., omphalitis and other skin infections, otitis, or urinary infections), and severe cases have been reported (e.g., pneumonia, sepsis, or meningitis). However, as neutropenia may also be an early presenting sign of sepsis in neonates, it can be difficult to determine whether the sepsis preceded the neutropenia or vice versa. In NAIN, neutropenia is typically associated with monocytosis and sometimes with eosinophilia. Hemoglobin values and platelet counts are within the reference intervals, as in this case (3 ). Bone marrow aspiration, which is rarely performed, typically shows a normocellular marrow with late granulocytic maturation arrest.
Neutropenia may last up to 6 months (median, 7 weeks). Serial blood cell counts should be performed until correction of neutropenia, which is usually preceded by a decrease in monocytes. NAIN management is mainly based on prevention of infection. Skin hygiene and careful disinfection of baby bottles and nipples are essential. Prophylactic antibiotic therapy, intravenous immunoglobulins, and recombinant human granulocyte colony-stimulating factor therapy remain controversial. A rapid discharge from the hospital, even in the absence of correction of neutropenia, is recommended by many authors to limit potential exposure to hospital-acquired infections. This approach should be considered only if the parents are able to quickly detect signs of infection and refer the neonate to the hospital (3 ).
The risk of NAIN recurrence is very high in subsequent pregnancies and depends on whether the father's granulocyte genotype is homozygous or heterozygous for the targeted antigen. Although no specific investigation is required during pregnancy, a blood cell count should be performed at birth and appropriate clinical management instituted in case of neutropenia.
In this case, no infectious complication was observed and, without any specific treatment, ANC spontaneously increased to 7.1ϫ10 
POINTS TO REMEMBER
• NAIN is caused by feto-maternal granulocyte incompatibility. It has been considered to be the granulocyte counterpart of FNAIT and of HDN.
• Although granulocytes express HLA class I at their surface, NAIN is mainly due to alloantibodies directed against neutrophil-specific alloantigens.
• NAIN can occur during a first pregnancy; there is no risk to the baby during pregnancy and the course of pregnancy is uneventful.
• The neonate may be asymptomatic or may develop infection ranging from mild to severe.
• The risk of NAIN recurrence is very high in subsequent pregnancies. Although no specific investigation is required during pregnancy, a blood cell count should be performed at birth.
